HK1019338A1 - Phosphonic acid-substituted benzazepinone-n-aceticacid derivatives, and processes for their prepara tion and pharmaceuticals comprising these compounds. - Google Patents

Phosphonic acid-substituted benzazepinone-n-aceticacid derivatives, and processes for their prepara tion and pharmaceuticals comprising these compounds.

Info

Publication number
HK1019338A1
HK1019338A1 HK99104433A HK99104433A HK1019338A1 HK 1019338 A1 HK1019338 A1 HK 1019338A1 HK 99104433 A HK99104433 A HK 99104433A HK 99104433 A HK99104433 A HK 99104433A HK 1019338 A1 HK1019338 A1 HK 1019338A1
Authority
HK
Hong Kong
Prior art keywords
aceticacid
pharmaceuticals
derivatives
compounds
processes
Prior art date
Application number
HK99104433A
Other languages
English (en)
Inventor
Harald Waldeck
Joerg Meil
Dirk Thormaehlen
Michael Wurl
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of HK1019338A1 publication Critical patent/HK1019338A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK99104433A 1997-11-12 1999-10-08 Phosphonic acid-substituted benzazepinone-n-aceticacid derivatives, and processes for their prepara tion and pharmaceuticals comprising these compounds. HK1019338A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19750002A DE19750002A1 (de) 1997-11-12 1997-11-12 Phosphonsäure-substituierte Benzazepinon-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
HK1019338A1 true HK1019338A1 (en) 2000-02-03

Family

ID=7848410

Family Applications (1)

Application Number Title Priority Date Filing Date
HK99104433A HK1019338A1 (en) 1997-11-12 1999-10-08 Phosphonic acid-substituted benzazepinone-n-aceticacid derivatives, and processes for their prepara tion and pharmaceuticals comprising these compounds.

Country Status (28)

Country Link
US (1) US5952327A (xx)
EP (1) EP0916679B1 (xx)
JP (1) JP4162780B2 (xx)
KR (1) KR19990045100A (xx)
CN (1) CN1187361C (xx)
AR (1) AR009911A1 (xx)
AT (1) ATE228144T1 (xx)
AU (1) AU746907B2 (xx)
BR (1) BR9804582A (xx)
CA (1) CA2253997C (xx)
CZ (1) CZ296123B6 (xx)
DE (2) DE19750002A1 (xx)
DK (1) DK0916679T3 (xx)
DZ (1) DZ2652A1 (xx)
ES (1) ES2186961T3 (xx)
HK (1) HK1019338A1 (xx)
HU (1) HU221177B1 (xx)
ID (1) ID21393A (xx)
IL (1) IL126984A (xx)
NO (1) NO317640B1 (xx)
NZ (1) NZ332744A (xx)
PL (1) PL191436B1 (xx)
PT (1) PT916679E (xx)
RU (1) RU2211219C2 (xx)
SK (1) SK283233B6 (xx)
TR (1) TR199802289A3 (xx)
UA (1) UA60304C2 (xx)
ZA (1) ZA9810316B (xx)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL367093A1 (en) * 2001-05-18 2005-02-21 Solvay Pharmaceuticals Gmbh Use of compounds with combined nep/mp-inhibitory activity in the preparation of medicaments
WO2003059939A1 (en) * 2002-01-16 2003-07-24 Solvay Pharmaceuticals B.V. Solid salts benzazepine compounds and their use in the preparation of pharmaceuticals compounds
CL2004000544A1 (es) * 2003-03-18 2005-01-28 Pharmacia Corp Sa Organizada B Uso de una combinacion farmaceutica, de un antagonista del receptor de aldosterona y un inhibidor de endopeptidasa neutral, util para el tratamiento y prevencion de una condicion patologica relacionada con hipertension, disfuncion renal, insulinopati
US7262184B2 (en) 2003-09-26 2007-08-28 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
US7427611B2 (en) * 2003-09-26 2008-09-23 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 1-(carboxyalkyl)-cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
US7452875B2 (en) 2003-09-26 2008-11-18 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
SA04250283B1 (ar) * 2003-09-26 2008-05-26 سولفاي فارماسيتيكالز جي أم بي أتش مشتقات من amidomethy1-substituted1-(carboxyalkyl)-cyclopentylcarbonylamino-benzazepine-N-acetic acid
US7232813B2 (en) * 2004-01-12 2007-06-19 Solvay Pharmaceuticals B.V. Neutral endopeptidase (NEP) and human soluble endopeptidase (hSEP) inhibitors for prophylaxis and treatment of neuro-degenerative disorders
WO2005067937A1 (en) * 2004-01-12 2005-07-28 Solvay Pharmaceuticals B.V. Neutral endopeptidase (nep) and human soluble endopeptidase (hsep) inhibitors for prophylaxis and treatment of neurodegenerative disorders
US20050267072A1 (en) * 2004-05-14 2005-12-01 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions containing dually acting inhibitors of neutral endopeptidase for the treatment of sexual dysfunction
US20050267124A1 (en) * 2004-05-14 2005-12-01 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous producing system and PDEV inhibiitors
US20050288272A1 (en) * 2004-06-23 2005-12-29 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and AT1 receptor antagonists
US7816347B2 (en) 2004-12-15 2010-10-19 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and HMG CoA reductase inhibitors
US20060205625A1 (en) * 2005-02-18 2006-09-14 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and diuretics
WO2007102171A2 (en) * 2006-03-07 2007-09-13 Panacea Biotec Ltd Novel salts of 1h-1-benzazepine-1-acetic acid, their preparation and pharmaceutical composition
US8198341B2 (en) 2008-12-18 2012-06-12 Icl-Ip America Inc. Method of making hydroxymethylphosphonate, polyurethane foam-forming compositions, polyurethane foam and articles made therefrom
EP2909218B1 (en) 2012-10-17 2019-07-10 ICL-IP America Inc. Method of making hydroxymethylphosphonate, polyurethane foam-forming compositions, polyurethane foam and articles made therefrom
US9528269B2 (en) 2014-06-09 2016-12-27 Johns Manville Roofing systems and roofing boards with non-halogenated fire retardant
US9815256B2 (en) 2014-06-09 2017-11-14 Johns Manville Foam boards including non-halogenated fire retardants
US9523195B2 (en) 2014-06-09 2016-12-20 Johns Manville Wall insulation boards with non-halogenated fire retardant and insulated wall systems
US9815966B2 (en) 2014-07-18 2017-11-14 Johns Manville Spray foams containing non-halogenated fire retardants
CN107383084A (zh) * 2017-06-14 2017-11-24 浙江嘉华化工有限公司 一种0‑乙基磷酸钠的制备方法
PL424453A1 (pl) * 2018-01-31 2019-08-12 Forty-Four Pharmaceuticals Spółka Z Ograniczoną Odpowiedzialnością Sposoby zmniejszania szkodliwego działania niedoboru perfuzji narządów miąższowych przez inhibitory obojętnej endopeptydazy (NEP) i ludzkiej rozpuszczalnej endopeptydazy (hSEP)
PL424452A1 (pl) 2018-01-31 2019-08-12 Forty-Four Pharmaceuticals Spółka Z Ograniczoną Odpowiedzialnością Inhibitory obojętnej endopeptydazy (NEP) i ludzkiej rozpuszczalnej endopeptydazy (hSEP) do profilaktyki i leczenia chorób oczu

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19510566A1 (de) * 1995-03-23 1996-09-26 Kali Chemie Pharma Gmbh Benzazepin-, Benzoxazepin- und Benzothiazepin-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US5877313A (en) * 1995-05-17 1999-03-02 Bristol-Myers Squibb Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ACE and NEP
US5635504A (en) * 1995-06-07 1997-06-03 Bristol-Myers Squibb Co. Diazepine containing dual action inhibitors

Also Published As

Publication number Publication date
DE59806345D1 (de) 2003-01-02
PT916679E (pt) 2003-03-31
NO317640B1 (no) 2004-11-29
TR199802289A2 (xx) 1999-06-21
CA2253997A1 (en) 1999-05-12
ID21393A (id) 1999-06-03
NO985262D0 (no) 1998-11-11
AU9234498A (en) 2000-06-08
ES2186961T3 (es) 2003-05-16
CZ356298A3 (cs) 1999-06-16
EP0916679A1 (de) 1999-05-19
DK0916679T3 (da) 2002-12-16
CA2253997C (en) 2009-05-12
TR199802289A3 (tr) 1999-06-21
IL126984A (en) 2001-07-24
PL329635A1 (en) 1999-05-24
HUP9802517A3 (en) 2000-06-28
NO985262L (no) 1999-05-14
PL191436B1 (pl) 2006-05-31
ATE228144T1 (de) 2002-12-15
UA60304C2 (uk) 2003-10-15
DE19750002A1 (de) 1999-05-20
JP4162780B2 (ja) 2008-10-08
HU221177B1 (en) 2002-08-28
RU2211219C2 (ru) 2003-08-27
BR9804582A (pt) 2000-05-09
HUP9802517A2 (hu) 1999-09-28
EP0916679B1 (de) 2002-11-20
SK151698A3 (en) 1999-05-07
US5952327A (en) 1999-09-14
NZ332744A (en) 2000-06-23
AU746907B2 (en) 2002-05-02
HU9802517D0 (en) 1998-12-28
DZ2652A1 (fr) 2003-03-15
CN1187361C (zh) 2005-02-02
CN1217334A (zh) 1999-05-26
AR009911A1 (es) 2000-05-03
JPH11292886A (ja) 1999-10-26
SK283233B6 (sk) 2003-04-01
ZA9810316B (en) 1999-05-18
CZ296123B6 (cs) 2006-01-11
IL126984A0 (en) 1999-09-22
KR19990045100A (ko) 1999-06-25

Similar Documents

Publication Publication Date Title
HK1019338A1 (en) Phosphonic acid-substituted benzazepinone-n-aceticacid derivatives, and processes for their prepara tion and pharmaceuticals comprising these compounds.
HK1046451A1 (en) Cooperative error handling system.
ZA9811339B (en) Benzamidine derivatives.
ZA989061B (en) Medicaments.
HK1037974A1 (en) Pharmaceutical formulations for aerosols with two or more active substances.
HK1028344A1 (en) Resorcinol derivatives.
HUP0001539A3 (en) 2-(1-iminoethylamino)ethyl-homocysteine, process for its preparation and pharmaceutical compositions containing the same
ZA993338B (en) Pharmaceutical formulations.
AU6405198A (en) Plant for the treatment of products, which includes means for characterizing the products
ZA985364B (en) Pharmaceutical formulations containing voriconazole.
HK1027957A1 (en) Pharmaceutical composition.
ZA98111B (en) Absorbent products having conforming means.
ZA200104280B (en) Pharmaceutical combination preparations.
ZA971850B (en) New aryl glycine amide derivatives, processes for preparing them and pharmaceutical compositions containing these compounds.
ZA9811504B (en) Novel pharmaceutical.
HK1015789A1 (en) Propanolamine derivatives, processes for their preparation, pharmaceuticals comprising these compounds, and their use.
ZA99283B (en) Inhaler for medication.
ZA9811506B (en) Novel pharmaceutical.
ZA989680B (en) Pharmaceutical composition.
HUP0001923A3 (en) Pesticidal 1-aryl-3-iminopyrazoles, process for their preparation, their use
ZA9811505B (en) Novel pharmaceutical.
ZA988711B (en) New tetracycles, process for their production and pharmaceutical preparations containing these compounds.
HK1030610A1 (en) Improved process for antiparaistic agent.
ZA987392B (en) Pharmaceutical composition.
HK1040488A1 (en) Pharmaceutical formulations.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20111110